Person:
Grune, Jana

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Grune

First Name

Jana

Name

Grune, Jana

Filters

20201

Settings

Author's Publications: search.filters.isAuthorOfPublication.b886d362-c9ee-457a-91ed-0bfe771f560b

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Publication
    Multimodal imaging of bacterial-host interface in mice and piglets with Staphylococcus aureus endocarditis
    (American Association for the Advancement of Science (AAAS), 2020-11-04) Panizzi, Peter; Krohn-Grimberghe, Marvin; Keliher, Edmund J.; Ye, Yu-Xiang; Grune, Jana; Frodermann, Vanessa; Sun, Yuan; Muse, Charlotte G.; Bushey, Kaitlyn; Iwamoto, Yoshiko; van Leent, Mandy M. T.; Meerwaldt, Anu; Toner, Yohana C.; Munitz, Jazz; Maier, Alexander; Soultanidis, Georgios; Calcagno, Claudia; Pérez-Medina, Carlos; Carlucci, Giuseppe; Riddell, Kay P.; Barney, Sharron; Horne, Glenn; Anderson, Brian; Maddur-Appajaiah, Ashoka; Verhamme, Ingrid M.; Bock, Paul E.; Wojtkiewicz, Gregory R.; Courties, Gabriel; Swirski, Filip; Church, William R.; Walz, Paul H.; Tillson, D. Michael; Mulder, Willem J. M.; Nahrendorf, Matthias
    Acute bacterial endocarditis is a rapid, difficult to manage and frequently lethal disease. Even potent antibiotics often cannot efficiently kill Staphylococcus aureus (S. aureus) that colonizes the heart’s valves. S. aureus relies on virulence factors to evade therapeutics and the host’s immune response. For instance, S. aureus usurps the host’s clotting system by activating circulating prothrombin with staphylocoagulase and von Willebrand factor-binding protein. An insoluble fibrin barrier then forms around the bacterial colony, shielding the pathogen from immune cell clearance. Targeting virulence factors may provide new avenues to better diagnose and treat endocarditis. To tap into this unused therapeutic opportunity, we co-developed therapeutics and multimodal molecular imaging to probe the host-pathogen interface. We introduced and validated a family of small-molecule optical and PET reporters targeting active thrombin in the fibrin-rich environment of bacterial colonies. The imaging agents, based on the clinical thrombin inhibitor dabigatran, bound to heart valve vegetations in mice. Aortic or tricuspid S. aureus endocarditis in piglets was successfully imaged with clinical PET/MRI. We employed optical imaging to monitor therapy with antibodies neutralizing staphylocoagulase and von Willebrand factor binding protein in mice with S. aureus endocarditis. This treatment deactivated bacterial defenses against innate immune cells, decreased in vivo imaging signal and improved survival. Our data map a route towards adjuvant immunotherapy for endocarditis and provide efficient tools to monitor this drug class for infectious diseases.